These regulatory features may include metabolic features of the tumor—for instance, it has been reported that oxidized cholesterol ligands secreted from tumors can suppress the expression of CCR7 in DCs-, and this impairs the migration from the tumor to TdLN (52). The gene discussed is CCR7; the disease is neoplasm.